Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's high margin levels account for strong profits.

● Its low valuation, with P/E ratio at 1.93 and 6.33 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's earnings growth outlook lacks momentum and is a weakness.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.